Results 201 to 210 of about 548,791 (262)
Liver Organoids: From Disease Modelling to Regenerative Medicine
Liver organoids provide a versatile platform for disease modelling and drug discovery, leveraging stem cells and engineering techniques. They bridge research and clinical applications, offering significant potential for advancing precision medicine and regenerative therapies for liver diseases.
Tiepeng Wang +5 more
wiley +1 more source
Temperature Safeguards and Peri-Procedural Strategies for Stem Cell Collection in Cold Agglutinin Disease: A Case Report and Literature Review. [PDF]
Bellegarde S +5 more
europepmc +1 more source
The different face of skin‐rash induced by brentuximab vedotin
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri +11 more
wiley +1 more source
Multidisciplinary Team Nursing Care During Peri-Transplantation for ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report. [PDF]
Hong X, Wang G, Cai L, Lin Y, Zhao Y.
europepmc +1 more source
ABSTRACT Background/Aim This in vitro study evaluated whether liquid platelet‐rich fibrin could maintain or recover periodontal ligament cell viability in extracted human teeth after three and four hours of dry extra‐alveolar time. Material and Methods Sixty‐six erupted third molars with complete root formation were allocated to four groups: three‐hour
Tatiana Carvalho Kowaltschuk +6 more
wiley +1 more source
Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study. [PDF]
Hu S +18 more
europepmc +1 more source
ABSTRACT Multiple myeloma (MM) is predominantly a disease of older adults, yet the randomized clinical trials (RCTs) that define standards of care are conducted largely in younger, fitter, and less comorbid populations. This creates a systematic mismatch between the populations generating evidence and those receiving treatment in routine practice ...
Enrica Antonia Martino +13 more
wiley +1 more source
Tacrolimus-resistant regulatory T cells: Combining the best of both worlds? [PDF]
Kuypers D.
europepmc +1 more source

